Pharmacogenomics: Tailoring drug therapies for improved outcomes

While research from as far back as the 1960's indicates that genetic variations are directly responsible for different medication responses, only recently have the reduced costs of testing made the benefits of pharmacogenomics (PGx) available to many patients. While the list of clinical trials and PGx tests is continually expanding, many medications are not yet associated with clinically useful guidance.

Download White Paper

You may also like:

Blog Post

It has been exciting for me to relive the successful mission of Apollo 11 to the moon on July 20, 1969. Were you alive on that summer day when histo...

View Blog Post
Blog Post

Patient education has become a key element of the patient care and treatment experience. Whether at office visits, in care settings, or through patient portals, distributing information on conditions, medications, and follow-up...

View Blog Post
Blog Post

Everyday there are more news headlines about policymakers addressing different approaches to lowering healthcare and prescription drug costs. This spring alone saw news about the

View Blog Post

Filter by Type

Sign up to receive the latest news and information!

Sign Up